<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474327/" ref="ordinalpos=445&amp;ncbi_uid=4782640&amp;link_uid=PMC3474327" image-link="/pmc/articles/PMC3474327/figure/F4/" class="imagepopup">Figure 4. Smad-Dependent BMP <span class="highlight" style="background-color:">Signaling</span> Is Required for Lung Differentiation.  From: Generation of Multipotent Lung and Airway Progenitors from Mouse ESCs and Patient-Specific Cystic Fibrosis iPSCs. </a></div><br /><div class="p4l_captionBody">(A) NKX2.1 induction with 20 ng/ml FGF2 and 5 nM GSK3iXV only (control) or with additional BMP4 (20 ng/ml), BMP2 (20 ng/ml), BMP7 (20 ng/ml), BMP4 (20 ng/ml) + 10 μM Dorsomorphin, or BMP4 (20 ng/ml) + 1 μM PD98059. Scale bar, 100 μm.(B) BMP signaling through SMAD-dependent pathways is required for lung Nkx2.1+ differentiation. In contrast, signaling through the MAP kinase pathway is not required for Nkx2.1 expression. Dorsomorphin inhibits BMP signaling through the SMAD pathway while PD98059 inhibits MAPK signaling.</div></div>